The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation
Open Access
- 28 May 2020
- Vol. 9 (6), 1354
- https://doi.org/10.3390/cells9061354
Abstract
NSIAD is a rare X-linked condition, caused by activating mutations in the AVPR2 gene coding for the vasopressin V2 receptor (V2R) associated with hyponatremia, despite undetectable plasma vasopressin levels. We have recently provided in vitro evidence that, compared to V2R-wt, expression of activating V2R mutations R137L, R137C and F229V cause a constitutive redistribution of the AQP2 water channel to the plasma membrane, higher basal water permeability and significantly higher basal levels of p256-AQP2 in the F229V mutant but not in R137L or R137C. In this study, V2R mutations were expressed in collecting duct principal cells and the associated signalling was dissected. V2R-R137L and R137C mutants had significantly higher basal pT269-AQP2 levels -independently of S256 and PKA-which were reduced to control by treatment with Rho kinase (ROCK) inhibitor. Interestingly, ROCK activity was found significantly higher in V2R-R137L along with activation of the Gα12/13–Rho–ROCK pathway. Of note, inhibition of ROCK reduced the basal elevated osmotic water permeability to control. To conclude, our data demonstrate for the first time that the gain-of-function mutation of the V2R, R137L causing NSIAD, signals through an alternative PKA-independent pathway that increases AQP2 membrane targeting through ROCK-induced phosphorylation at S/T269 independently of S256 of AQP2.Funding Information
- Fondazione Telethon (GGP13227)
This publication has 48 references indexed in Scilit:
- Calcium-Sensing Receptor and Aquaporin 2 Interplay in Hypercalciuria-Associated Renal Concentrating Defect in Humans. An In Vivo and In Vitro StudyPLOS ONE, 2012
- V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R AntagonistsOnline Journal of Public Health Informatics, 2012
- Functional Characterization of Vasopressin Type 2 Receptor Substitutions (R137H/C/L) Leading to Nephrogenic Diabetes Insipidus and Nephrogenic Syndrome of Inappropriate Antidiuresis: Implications for TreatmentsMolecular Pharmacology, 2010
- Phosphorylation of aquaporin-2 regulates its endocytosis and protein–protein interactionsProceedings of the National Academy of Sciences of the United States of America, 2009
- Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cellsKidney International, 2009
- Vasopressin-stimulated Increase in Phosphorylation at Ser269 Potentiates Plasma Membrane Retention of Aquaporin-2Online Journal of Public Health Informatics, 2008
- Quantitative phosphoproteomics of vasopressin-sensitive renal cells: Regulation of aquaporin-2 phosphorylation at two sitesProceedings of the National Academy of Sciences of the United States of America, 2006
- Nephrogenic Syndrome of Inappropriate AntidiuresisThe New England Journal of Medicine, 2005
- Conformational Activation of Radixin by G13 Protein α SubunitOnline Journal of Public Health Informatics, 2000
- Up-Regulation of p21- and RhoA-Activated Protein Kinases in Human Pregnant MyometriumBiochemical and Biophysical Research Communications, 2000